Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124651445 | 12465144 | 5 | F | 20160823 | 20160614 | 20160829 | EXP | US-PFIZER INC-2016295310 | PFIZER | 71.00 | YR | F | Y | 99.79000 | KG | 20160829 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124651445 | 12465144 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, 1X/DAY | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 124651445 | 12465144 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 37.5 MG, 1X/DAY | Y | 20699 | 37.5 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 124651445 | 12465144 | 3 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, DAILY | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124651445 | 12465144 | 1 | Neuropathy peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124651445 | 12465144 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124651445 | 12465144 | Agitation | |
| 124651445 | 12465144 | Appetite disorder | |
| 124651445 | 12465144 | Crying | |
| 124651445 | 12465144 | Dizziness | |
| 124651445 | 12465144 | Dry mouth | |
| 124651445 | 12465144 | Fall | |
| 124651445 | 12465144 | Fatigue | |
| 124651445 | 12465144 | Headache | |
| 124651445 | 12465144 | Insomnia | |
| 124651445 | 12465144 | Irritability | |
| 124651445 | 12465144 | Muscle spasms | |
| 124651445 | 12465144 | Nervousness | |
| 124651445 | 12465144 | Oedema | |
| 124651445 | 12465144 | Product use issue | |
| 124651445 | 12465144 | Pruritus | |
| 124651445 | 12465144 | Skin discolouration | |
| 124651445 | 12465144 | Skin haemorrhage | |
| 124651445 | 12465144 | Somnolence | |
| 124651445 | 12465144 | Vision blurred | |
| 124651445 | 12465144 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124651445 | 12465144 | 1 | 201408 | 0 | ||
| 124651445 | 12465144 | 3 | 20160225 | 20160616 | 0 |